Skip to content
Search

Latest Stories

Obesity crisis: 'Weight loss service through pharmacies would yield better outcomes'

Obesity crisis: 'Weight loss service through pharmacies would yield better outcomes'

Day Lewis is planning to launch a private weight loss service in January 2025 to help tackle the UK’s obesity crisis

Rachna Chhatralia, superintendent pharmacist at Day Lewis, has suggested that obesity should be a key focus area of the upcoming 10-year health plan.

She advocated for a weight loss service to be commissioned through community pharmacies to address this growing public health issue effectively.


"Obesity is a big problem in the UK, and it has progressively worsened as a result of COVID, with people being at home, unable to access gyms, and developing unhealthy eating habits,” Rachna told Pharmacy Business.

Rachna, the winner of the Pharmacy Business’ Aspiring Pharmacy Leader of the Year, emphasised the urgent need to tackle obesity as it can lead to other long-term conditions in the long run and cost the NHS a lot of money.

“If you don't try and tackle the obesity rate, you're then looking at treatment for other comorbidities, such as hypertension, diabetes, and cardiovascular issues, including heart attack and strokes. It just spirals out of control,” she explained.

Rachna stated that Day Lewis plans to launch a private weight loss service in January 2025.

However, she believes having a commissioned weight loss service would be a great opportunity for the sector as a whole.

“We would reach out to all the patients who require it and provide them with suitable medication to support them, as well as appropriate coaching plans, including educating them about healthy eating, exercise, and other lifestyle choices.

“Additionally, we could monitor vital signs such as BMI, blood pressure, and blood sugar levels,” Rachna said.

When asked if pharmacies are adequately trained to offer a weight loss service, she responded, “Absolutely! 100 per cent. If you consider Healthy Living advice, it’s what we provide to our patients day in and day out.”

Rachna suggested that the government could also consider funding training to upskill community pharmacy teams.

She believes that delivering such an important service through community pharmacies would result in much better outcomes than if it were offered at a GP practice.

“You have skilled individuals available in community pharmacies, who are open long hours, and there’s a pharmacy at nearly every corner. I believe access would be far better, and in the long run, it would support the NHS.

“It would be more cost-effective to invest in pharmacy now to reduce the obesity rate within the population rather than delaying it and then facing the costs associated with the complications that can arise from obesity,” she added.

The latest data from the Department of Health and Social Care reveals that approximately two-thirds (63 per cent) of adults in England are above a healthy weight, with half of those classified as living with obesity.

Additionally, in England, one in three children finishing primary school are overweight or living with obesity, with one in five classified as living with obesity.

Obesity rates are highest among the most deprived groups in society, with children living in the most deprived parts of the country more than twice as likely to be living with obesity than those in the least deprived areas.

Untitled 1 Rachna Chhatralia, posing with the Pharmacy Business Aspiring Pharmacy Leader of the Year award.

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less